DSM certified for potent compounds

DSM Pharmaceuticals has earned the SafeBridge Potent Compound Safety Certification for the handling of potent active pharmaceutical ingredients and drug products. The certification applies to a sterile fill/finish production area within the company's Greenville, NC, facility that includes a high-containment area and associated quality control labs.

SafeBridge conducted its 60-element review of programs, procedures, containment and control of APIs at the site. Quantitative results determine that DSM qualifies for the certification.

SafeBridge in July certified SAFC, a member of the Sigma-Aldrich group, for the high-potency suite for antibody drug conjugate manufacturing and process development and associated quality-control labs at a St. Louis facility. Both SAFC and DSM hold the SafeBridge certification for high-potency areas at other facilities as well. They are joined by Lonza and Ferro-Pfanstiehl as certificate holders.

- here's the announcement

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.